None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Yongin Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults aged 19 years or older. 2) Patients hospitalized for acute ischemic stroke within 7 days of symptom onset, confirmed through Brain CT or MRI. 3) Patients who are receiving antithrombotic treatment. 4) Patients with a Gastroesophageal Reflux Disease Questionnaire (GerdQ) score of 8 or higher at the time of screening. 5) Patients who are receiving treatment with Fexuprazan. 6) Individuals who have voluntarily provided written informed consent to participate in this clinical trial.
Exclusion criteria
Exclusion criteria: 1) Patients who have undergone intravenous thrombolysis and/or intra-arterial thrombectomy for the treatment of ischemic stroke. 2) Individuals who have had an allergic reaction to Fexuprazan. 3) Patients who are unable to complete the GerdQ questionnaire. 4) Pregnant or breastfeeding individuals. 5) Individuals who have participated in another drug clinical trial within the past month, except for observational studies, in which case participation in this clinical trial is allowed. 6) Individuals whom the investigator deems inappropriate for participation in the clinical trial for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastroesophageal reflux disease questionnaire (GerdQ) | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical event of upper gastrointestinal complications as a complication of gastroesophageal reflux disease. | — |
Countries
Korea, Republic of
Contacts
Public ContactJeonga Shin
Yonsei University Yongin Severance Hospital
Outcome results
None listed